These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12022872)

  • 41. Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties.
    Boffa MB; Wang W; Bajzar L; Nesheim ME
    J Biol Chem; 1998 Jan; 273(4):2127-35. PubMed ID: 9442053
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The intrinsic threshold of the fibrinolytic system is modulated by basic carboxypeptidases, but the magnitude of the antifibrinolytic effect of activated thrombin-activable fibrinolysis inhibitor is masked by its instability.
    Walker JB; Bajzar L
    J Biol Chem; 2004 Jul; 279(27):27896-904. PubMed ID: 15128744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator. A potential mechanism for enhancing the fibrin specificity of tissue plasminogen activator.
    Stewart RJ; Fredenburgh JC; Rischke JA; Bajzar L; Weitz JI
    J Biol Chem; 2000 Nov; 275(47):36612-20. PubMed ID: 10970891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of heparin interaction sites on thrombin-activatable fibrinolysis inhibitor that modulate plasmin-mediated activation, thermal stability, and antifibrinolytic potential.
    Marar TT; Boffa MB
    Res Pract Thromb Haemost; 2024 May; 8(4):102459. PubMed ID: 38983903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The TAFI system. The new role of fibrinolysis].
    Dempfle CE
    Hamostaseologie; 2007 Sep; 27(4):278-81. PubMed ID: 17938767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Regulatory mechanism of fibrinolysis system by thrombin activatable fibrinolysis inhibitor (TAFI)].
    Urano T
    Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):298-303. PubMed ID: 11215380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure-function relationships in thrombin-activatable fibrinolysis inhibitor.
    Plug T; Meijers JC
    J Thromb Haemost; 2016 Apr; 14(4):633-44. PubMed ID: 26786060
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generation of a stable activated thrombin activable fibrinolysis inhibitor variant.
    Ceresa E; Van de Borne K; Peeters M; Lijnen HR; Declerck PJ; Gils A
    J Biol Chem; 2006 Jun; 281(23):15878-83. PubMed ID: 16595693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the profibrinolytic properties of an anti-TAFI monoclonal antibody in a mouse thromboembolism model.
    Vercauteren E; Emmerechts J; Peeters M; Hoylaerts MF; Declerck PJ; Gils A
    Blood; 2011 Apr; 117(17):4615-22. PubMed ID: 21343611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biochemical importance of glycosylation in thrombin activatable fibrinolysis inhibitor.
    Buelens K; Hillmayer K; Compernolle G; Declerck PJ; Gils A
    Circ Res; 2008 Feb; 102(3):295-301. PubMed ID: 18063813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative evaluation of stable TAFIa variants: importance of alpha-helix 9 and beta-sheet 11 for TAFIa (in)stability.
    Ceresa E; De Maeyer M; Jonckheer A; Peeters M; Engelborghs Y; Declerck PJ; Gils A
    J Thromb Haemost; 2007 Oct; 5(10):2105-12. PubMed ID: 17666015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complex.
    Wu C; Kim PY; Manuel R; Seto M; Whitlow M; Nagashima M; Morser J; Gils A; Declerck P; Nesheim ME
    J Biol Chem; 2009 Mar; 284(11):7059-67. PubMed ID: 19074424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutations in the substrate binding site of thrombin-activatable fibrinolysis inhibitor (TAFI) alter its substrate specificity.
    Zhao L; Buckman B; Seto M; Morser J; Nagashima M
    J Biol Chem; 2003 Aug; 278(34):32359-66. PubMed ID: 12799375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thrombin activatable fibrinolysis inhibitor (TAFI): a role in pre-eclampsia?
    Dusse LM; Cooper AJ; Lwaleed BA
    Clin Chim Acta; 2007 Mar; 378(1-2):1-6. PubMed ID: 17184758
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review.
    Sillen M; Declerck PJ
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916027
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A functional assay for measuring activated thrombin-activatable fibrinolysis inhibitor in plasma.
    Neill EK; Stewart RJ; Schneider MM; Nesheim ME
    Anal Biochem; 2004 Jul; 330(2):332-41. PubMed ID: 15203340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparins.
    Semeraro F; Ammollo CT; Semeraro N; Colucci M
    Haematologica; 2009 Jun; 94(6):819-26. PubMed ID: 19377079
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS).
    Grosso G; Vikerfors A; Woodhams B; Adam M; Bremme K; Holmström M; Ågren A; Eelde A; Bruzelius M; Svenungsson E; Antovic A
    Thromb Res; 2017 Oct; 158():168-173. PubMed ID: 28669410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insights into the molecular inactivation mechanism of human activated thrombin-activatable fibrinolysis inhibitor.
    Sanglas L; Arolas JL; Valnickova Z; Aviles FX; Enghild JJ; Gomis-Rüth FX
    J Thromb Haemost; 2010 May; 8(5):1056-65. PubMed ID: 20088943
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary Hypertension: A Possible Novel Therapeutic Target.
    Satoh T; Satoh K; Yaoita N; Kikuchi N; Omura J; Kurosawa R; Numano K; Al-Mamun E; Siddique MA; Sunamura S; Nogi M; Suzuki K; Miyata S; Morser J; Shimokawa H
    Circ Res; 2017 Apr; 120(8):1246-1262. PubMed ID: 28289017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.